BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 Telaprevir for previously untreated chronic hepatitis C virus infection.
24 auth. I. Jacobson, J. Mchutchison, G. Dusheiko, A. Bisceglie, K. Reddy, N. Bzowej, P. Marcellin, A. Muir, P. Ferenci, R. Flisiak, ... J. George, M. Rizzetto, D. Shouval, R. SolΓ‘, R. Terg, E. Yoshida, N. Adda, L. Bengtsson, A. Sankoh, Tara L. Kieffer, S. George, R. Kauffman, S. Zeuzem, V. Phar
11 2011
11
🐜
🐜 Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
9 auth. A. Regev, M. Berho, L. Jeffers, C. Milikowski, E. Molina, N. Pyrsopoulos, ... Zheng Feng, K. Reddy, E. Schiff
11 2002
11
🐜
🐜 Boceprevir for untreated chronic HCV genotype 1 infection.
15 auth. F. Poordad, J. McCone, B. Bacon, S. Bruno, Michael P. Manns, M. Sulkowski, I. Jacobson, K. Reddy, Z. Goodman, N. Boparai, ... M. Dinubile, V. Sniukiene, C. Brass, J. Albrecht, J. Bronowicki
10 2011
10
🐜
🐜 Sofosbuvir for previously untreated chronic hepatitis C infection.
24 auth. E. Lawitz, A. Mangia, D. Wyles, M. Rodríguez-Torres, T. Hassanein, S. Gordon, M. Schultz, Mitchell N. Davis, Z. Kayali, K. Reddy, ... I. Jacobson, K. Kowdley, L. Nyberg, G. Subramanian, R. Hyland, S. Arterburn, D. Jiang, J. McNally, D. Brainard, W. Symonds, J. Mchutchison, A. Sheikh, Z. Younossi, E. Gane
10 2013
10
🐜
🐜 Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
25 auth. N. Afdhal, K. Reddy, D. Nelson, E. Lawitz, S. Gordon, E. Schiff, R. Nahass, R. Ghalib, N. Gitlin, R. Herring, J. Lalezari, Z. Younes, P. Pockros, A. D. Di Bisceglie, Sanjeev Arora, ... G. Subramanian, Yanni Zhu, H. Dvory‐Sobol, Jenny C. Yang, P. Pang, W. Symonds, J. Mchutchison, A. Muir, M. Sulkowski, P. Kwo
10 2014
10
🐜
🐜 Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
25 auth. K. Kowdley, S. Gordon, K. Reddy, L. Rossaro, D. Bernstein, E. Lawitz, M. Shiffman, E. Schiff, R. Ghalib, M. Ryan, V. Rustgi, M. Chojkier, R. Herring, A. D. Di Bisceglie, P. Pockros, ... G. Subramanian, D. An, E. Svarovskaia, R. Hyland, P. Pang, W. Symonds, J. Mchutchison, A. Muir, D. Pound, M. Fried
10 2014
10
🐜
🐜 Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
51 auth. M. Charlton, G. Everson, S. Flamm, Princy N. Kumar, C. Landis, Robert S. Brown, M. Fried, N. Terrault, J. O’Leary, H. Vargas, A. Kuo, E. Schiff, M. Sulkowski, R. Gilroy, K. Watt, ... K. Brown, P. Kwo, S. Pungpapong, K. Korenblat, A. Muir, L. Teperman, R. Fontana, J. Denning, S. Arterburn, H. Dvory‐Sobol, T. Brandt-Sarif, P. Pang, J. Mchutchison, K. Reddy, N. Afdhal, M. Fried, K. Kowdley, N. Terrault, S. Flamm, J. Lake, G. Everson, M. Sulkowski, M. Curry, R. Reddy, H. Vargas, A. Muir, A. Zaman, R. Fontana, J. O’Leary, O. Shaikh, K. Korenblat, R. Stravitz, K. Watt, N. Menon, J. Bredfeldt, Carlos Romero‐Marrero
9 2015
9
🐜
🐜 Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
22 auth. Michael P. Curry, J. O’Leary, N. Bzowej, A. Muir, K. Korenblat, J. Fenkel, K. Reddy, E. Lawitz, S. Flamm, T. Schiano, ... L. Teperman, R. Fontana, EugeneR. Schiff, M. Fried, B. Doehle, D. An, J. McNally, A. Osinusi, D. Brainard, J. Mchutchison, Robert S. Brown, Michael Charlton
9 2015
9
🐜
🐜 Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
80 auth. N. Chalasani, H. Bonkovsky, R. Fontana, William M. Lee, A. Stolz, J. Talwalkar, K. Reddy, P. Watkins, VΓ­ctor M. Navarro, Huiman Barnhart, Jiezhun Gu, J. Serrano, J. Ahmad, N. Bach, M. Bansal, ... H. Barnhart, K. Beavers, H. Bonkovsky, F. Calvo, Charissa Y. Chang, H. Conjeevaram, Gregory E. Conner, J. Darling, Ynto S. de Boer, D. Dieterich, F. DiPaola, F. Durazo, James E. (Jay) Everhart, R. Fontana, M. Ghabril, D. Goldstein, Vani Gopalreddy, P. Grewal, P. Hayashi, J. Hoofnagle, N. Kaplowitz, S. Liangpunsakul, Steven M. Lichtman, Lawrence U. Liu, V. Navarro, J. Odin, S. Rossi, M. Russo, T. Schiano, J. Serrano, A. Sherker, R. Vuppalanchi, P. Watkins, S. Zacks, Amanda Balasco, Kristin Chesney, Audrey Corne, Sherrie Cummings, G. Groseclose, Alex Hammett, J. Hooker, Varun Kesar, Sophana Mao, Kenari Marks, R. McFadden, Yolanda Melgoza, Sherif Mikhail, S. Milstein, Wendy Morlan, V. Peacock, Nidia Rosado, T. Russell, Maricruz Vega, M. Verma, Patricia Walker, R. Yalamanchili, Michelle McClanahan-Crowder, K. Galan, Jiezhun (Sherry) Gu, T. Chau, K. Ragavan, H. Rostami, Carmel Puglisi-Scharenbroich, Rebecca J. Torrance, Rebekah Van Raaphorst
9 2015
9
🐜
🐜 Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
16 auth. J. Marrero, Ziding Feng, Yinghui Wang, M. Nguyen, A. Befeler, L. Roberts, K. Reddy, D. Harnois, J. Llovet, D. Normolle, ... Jackie Dalhgren, D. Chia, A. Lok, P. Wagner, S. Srivastava, M. Schwartz
9 2009
9
🐜
🐜 Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
33 auth. H. Ford, M. Bourliere, S. Gordon, S. Flamm, C. Cooper, A. Ramji, M. Tong, N. Ravendhran, J. Vierling, T. Tran, S. Pianko, M. Bansal, V. Ledinghen, R. Hyland, L. Stamm, ... H. Dvory‐Sobol, E. Svarovskaia, Jie Zhang, K. C. Huang, G. Subramanian, D. Brainard, J. Mchutchison, E. Verna, P. Buggisch, C. Landis, Z. Younes, M. Curry, S. Strasser, E. Schiff, K. Reddy, M. Manns, K. Kowdley, S. Zeuzem
9 2017
9
🐜
🐜 Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
31 auth. R. Chung, M. Ghany, A. Kim, K. Marks, S. Naggie, H. Vargas, A. Aronsohn, D. Bhattacharya, Tina Broder, Oluwaseun O Falade-Nwulia, R. Fontana, S. Gordon, T. Heller, S. Holmberg, R. Jhaveri, ... M. Jonas, J. Kiser, B. Linas, V. Lo Re, T. Morgan, R. Nahass, M. Peters, K. Reddy, A. Reynolds, John D. Scott, Gloria Searson, T. Swan, N. Terrault, S. Trooskin, J. Wong, K. Workowski
9 2018
9
🐜
🐜 Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapy
9 auth. D. Jensen, T. Morgan, P. Marcellin, P. Pockros, K. Reddy, S. Hadziyannis, ... P. Ferenci, A. Ackrill, B. Willems
9 2006
9
🐜
🦁 American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
K. Reddy, K. Beavers, S. Hammond, Joseph K. Lim, Y. Falck-Ytter
9 2015
9
🦁